Anti-inflammatory, anticoagulant and antioxidant effects of aqueous extracts from Moroccan thyme varieties  by Khouya, Tarik et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Pac J Trop Biomed 2015; 5(8): 636–644636Asian Paciﬁc Journal of Tropical Biomedicine
journal homepage: www.elsevier.com/locate/apjtbOriginal article http://dx.doi.org/10.1016/j.apjtb.2015.05.011*Corresponding author: Tarik Khouya, Laboratory of Biochemistry, Faculty of
Sciences and Techniques, University Moulay Ismail, 52000 Errachidia, Morocco.
Tel: +212 112603044589
E-mail: tarikkhouya@yahoo.com
Peer review under responsibility of Hainan Medical University.
Foundation Project: Supported by Department of Biology, Laboratory of
Biochemistry, Faculty of Sciences and Techniques, University Moulay Ismail, Erra-
chidia, Morocco.
2221-1691/Copyright © 2015 Hainan Medical University. Production and hosting by Elsevier (Singapore) Pte Ltd. This is
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Anti-inflammatory, anticoagulant and antioxidant effects of aqueous extracts from
Moroccan thyme varietiesTarik Khouya1*, Mhamed Ramchoun1, Abdelbassat Hmidani1, Souliman Amrani2, Hicham Harnaﬁ2,
1 1 1Mohamed Benlyas , Younes Filali Zegzouti , Chakib Alem
1Department of Biology, Faculty of Sciences and Techniques, University Moulay Ismail, 52000 Errachidia, Morocco
2Laboratory of Biochemistry, Department of Biology, Faculty of Sciences, University Mohamed First, 60000 Oujda, MoroccoARTICLE INFO
Article history:
Received 4 May 2015
Received in revised form 14 May
2015
Accepted 23 May 2015
Available online 11 July 2015
Keywords:
Anti-inﬂammatory
Coagulation
Antioxidant
Thyme
Polyphenol
RatABSTRACT
Objective: To evaluate the anti-inﬂammatory, anticoagulant and antioxidant effects of
aqueous extracts of thyme varieties from Moroccan.
Methods: The aqueous extracts of tree medicinal plants [Thymus atlanticus
(T. atlanticus), Thymus satureioides and Thymus zygis (T. zygis)] were screened for their
antioxidant activity using 1,1-diphenyl-2-picrylhydrazyl radical-scavenging, ferric
reducing antioxidant power assay, radical scavenging activity method, the inhibition of
2,2'-azobis (2-amidinopropane) dihydrochloride that induces oxidative erythrocyte he-
molysis and thiobarbituric acid reactive substances assay. The anti-inﬂammatory activity
of aqueous extracts was evaluated in vivo using croton oil-induced ear edema and
carrageenan-induced paw edema in mice and rats, respectively. This extracts were
evaluated in vitro for their anticoagulant activity at the different concentrations by partial
thromboplastin time and prothrombin time activated.
Results: All thyme varieties were found to possess considerable antioxidant activity and
potent anti-inﬂammatory activity in the croton oil-induced edema. Administration of
aqueous extracts of two varieties (50 mg/kg) (T. zygis and T. atlanticus) reduced
signiﬁcantly the carrageenan-induced paw edema similar to non-steroidal anti-inﬂam-
matory drug (indomethacin, 10 mg/kg). In partial thromboplastin time and prothrombin
time tests, T. atlanticus and T. zygis extracts showed the strongest anticoagulant activity.
In contrast, Thymus satureioides did not show the anticoagulant activity in these tests.
Conclusions: All aqueous extracts possess considerable antioxidant activity and are rich
in total polyphenol and ﬂavonoid but they act differently in the process of inﬂammatory
and coagulation studied. This study shows great variability of biological activities in
thyme varieties.1. Introduction
Inﬂammation is closely linked with other physiological sys-
tems including the coagulation-ﬁbronolytic system and oxidant-
antioxidant pathways [1]. Physiologically, the activation of
inﬂammation and the coagulation system in acute trauma isrecognized as a physiologic reaction to initiate healing and to
act as a barrier to injury propagation and infection [2].
Systemic inﬂammation will invariably lead to activation of the
coagulation system, but vice versa, components of the
coagulation system can markedly modulate the inﬂammatory
response [3]. Pathophysiologically, inﬂammation and the
coagulation system play crucial roles in the pathogenesis of
multiple chronic inﬂammatory disorders [4].
Physiological concentrations of free radicals are required to
mediate physiological processes such as inﬂammatory reaction
[5]. Indeed, during inﬂammation, cells of the immune system are
recruited to the site of damage. This results in respiratory burst,
an overproduction of reactive oxygen species that can propagate
inﬂammation by stimulating release of cytokines [6] and causean open access article under the CC BY-NC-ND
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eventually leads to chronic diseases, such as atherosclerosis,
cancer, diabetes, aging and other degenerative diseases [7,8].
Despite their incontestable efﬁcacy in the treatment of venous
thromboembolic and inﬂammatory diseases, the current treatments
of anticoagulants and the anti-inﬂammatory used for several de-
cades, present many limitations [9,10]. Side effects related to non-
steroidal anti-inﬂammatory drugs and heparins, administered
only by injection, have been extensively documented by numerous
clinical trials [10,11]. There is a need therefore to discover new anti-
inﬂammatory and anticoagulants which will present no undesir-
able effects [9,12]. Medicinal plants are believed to be an important
source for the discovery of potential anti-inﬂammatory and anti-
coagulant substances. Several plant extracts and different classes
of phytochemicals have been investigated and shown potential
anti-inﬂammatory and anticoagulant activity [9,12].
The genus Thymus L. (Lamiaceae), aromatic plants of the
Mediterranean ﬂora, economically important due to their use in
folk medicine for their numerous medicinal and aromatic
properties, have been reported to possess various biological ef-
fects including antioxidant and antimicrobial activities [13].
Many works showed that some Thymus species possess anti-
inﬂammatory activity but to our knowledge, no study has
investigated the effect of these plants on the coagulation.
Thymus satureioides (T. satureioides), Thymus atlanticus
(T. atlanticus) and Thymus zygis (T. zygis) are an endemic species
of Morocco [14] used in the folk medicine in form of infuse and
decoctions to treat whooping cough, bronchitis and rheumatism
and, generally, for its anti-inﬂammatory properties after topical
or oral administration [15]. Recently, Ramchoun et al., analyzed
the aqueous extracts of these plants for their
hypocholesterolemic and antioxidant activities and concluded
that all extracts possess considerable antioxidant activities but
only the T. atlanticus extract exhibits a potent hypolipidemic
capacity [14]. Indeed in the present work we conﬁrm, for the
ﬁrst time, previous established works by our group Ramchoun
et al., on the antioxidative stress activities of such plant extracts
by lipid peroxidation based on the thiobarbituric acid reactive
substances (TBARS) assay [14]. Moreover, the extracts were
evaluated in vivo for their anti-inﬂammatory activity in two ani-
mal models according to Tubaro et al. [16] and Winter et al. [17] in
mice and rats, respectively and in vitro for their anticoagulant
activity at the different concentrations by activated partial
thromboplastin time (APTT) and prothrombin time (PT).
2. Materials and methods
2.1. Plant material
Thyme varieties were collected in April–May 2014 in the
Errachidia Region, Morocco. They were identiﬁed by Dr. Ibn
Tatou and voucher specimens were deposited at the herbarium of
the Scientiﬁc Institute, UniversityMohammedV, Rabat, Morocco.
T. satureioides Cosson (No: RAB 77497), T. zygis subsp. gracilis
(Boiss.) R. Morales (No: RAB 77494) and T. atlanticus (Ball)
Roussine (No: RAB 77496) were screened for this study.
2.2. Animals
Male Wistar rats weighing 150–200 g and male wistar mice
weighing 20–30 g were used in this study. They were obtainedfrom the animal facility of the Biology Department (Faculty of
Sciences, Errachidia, Morocco) in accordance with international
guidelines [18]. They were allowed free access to standard dry
pellet diet and given water ad labium. The animals were
grouped and housed in appropriate cages at room temperature
of (22 ± 2) C.
2.3. Biochemical analysis of aqueous thyme extracts
2.3.1. Chemicals and drugs
All solvents used were obtained from Sigma Chemical Co.:
croton oil, indomethacin, carrageenan, Folin-Ciocalteu, caffeic
acid, rutin, 1,1-diphenyl-2-picrylhydrazil (DPPH), trolox, tri-
pyridyltriazine (TPTZ), 2,2'-azobis(2-amidinopropane) dihy-
drochloride (AAPH) and triton WR-1339.
2.3.2. Preparation of thyme extracts for biochemical and
antioxidant analysis
The plant material was dried at room temperature and
powdered (60 g) and extracted with 400 mL of distilled water in
a Soxhlet extractor for 16 h. The extracts were ﬁltered and
evaporated by rotary vapor. The yields of extraction were 10%,
10% and 7.6% for T. satureioides, T. zygis and T. atlanticus
respectively.
2.3.3. High-performance liquid chromatography
(HPLC)
The aqueous thyme extracts was analyzed by HPLC using a
Reprosil Pur C18 column equipped with a photodiode array
detector. Analysis was performed on a C18 analytical column
(250 mm × 3 mm) with a particle size of 5 mm thermostated at
28 C. Extract (100 mL) was separated at 28 C. The ﬂow rate
was 0.5 mL/min and the absorbance changes were monitored at
215, 250 and 280 nm. The solvents for chromatographic analysis
were: (A) methanol/water (20/80) + 0.2% glacial acetic acid and
(B) methanol/water (80/20) + 0.2% glacial acetic acid [100%
(A) and 0% (B) at 0 min, 50% (A) and 50% (B) during 10 min,
17% (A) and 83% (B) during 20 min, which was changed to
100% (A) and 0% (B) in 5 min (35 min, total time)]. The
retention time of standards and the corresponding UV spectra
were used for identiﬁcation of the compounds in thyme extracts.
2.3.4. Determination of total polyphenol content
The aqueous extracts of thyme was analyzed for its phenolic
content according to the Folin-Ciocalteu colorimetric method [19].
Aqueous extracts (30 mL, three replicates), 4.22 mL of distilled
water, 250 mL of the Folin-Ciocalteau reagent and 500 mL of
10% sodium carbonate were introduced into the test tubes. The
tubes were mixed and allowed to stand for 30 min. The absor-
bance was measured at 725 nm in a spectrophotometer and result
of phenolic content was expressed as caffeic acid equivalents (mg/
mg extract, mean ± SEM of three determinations).
2.3.5. Determination of ﬂavonoid contents
The ﬂavonoid contents of the extracts were determined
spectrophotometrically according to the procedure established
by Jay et al. [20]. This method is based on the formation of a
ﬂavonoid–aluminum complex, having its maximum absorption
at 430 nm. The reagent of AlCl3 is prepared by dissolving
133 mg of AlCl3 in 100 mL of a mixture solvent of methanol:
water: acetic acid (70:25:5, v/v/v). Aqueous extract (1 mL)
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tube was mixed, allowed to stand for 30 min and measured at
430 nm in a spectrophotometer. The result of ﬂavonoid
contents were expressed in mg per g of rutin equivalents.
2.4. Antioxidant study of thyme extracts
2.4.1. DPPH radical scavenging activity assay
The method widely used for a relatively rapid evaluation of
antioxidant activities was based on the principle of reduction of a
stable radical. DPPH is an unstable free radical that accepts an
electron or hydrogen radical to become a stable diamagnetic
molecule having a speciﬁc absorption at 517 nm which it gives a
violet color [21]. Reducing DPPH by an antioxidant is
accompanied by the transition from purple to yellow color of
the solution, measured by spectrophotometer. Trolox as DPPH-
scavenging compound was used as positive control. The antiox-
idant activity was estimated by percentage inhibition or percent-
age of antioxidant activity according to the following formula:
Antioxidant activityð%Þ=Abscontrol −Abstest
Abscontrol × 100
where Abs is the absorbance at a wavelength of 517 nm.
2.4.2. Ferric reducing antioxidant power (FRAP) assay
The method is based on the reduction of the Fe3+-TPTZ
complex to the ferrous form at low pH. The antioxidant activity
of the thyme extracts was measured by monitoring the change in
absorption at 593 nm. FRAP solution consists of acetate buffer
(300 mmol/L) at pH = 3.6, TPTZ and FeCl3 × 6 H2O (20 mmol/
L) (10v/1v/1v). According to Benzie and Strain's method, 10 mL
of the plant extract (0.5%) was added to the FRAP solution
(2 mL), and allowed to stand for 15 min and the absorbance was
measured at 593 nm with a spectrophotometer [22]. The result of
antioxidant power was expressed as trolox equivalents (mg/mg
extract, mean ± SEM of three determinations).
2.4.3. TBARS assay
The malondialdehyde (MDA) or TBARS assay was used to
measure the potential antioxidant capacity of thyme extracts,
using a rich plasma lipid that is taken frommice treated with triton
WR-1339 (600 mg/kg) according to the procedure established by
Park et al. [23]. The TBARS assay quantiﬁes oxidative stress by
measuring the peroxidative damage to lipids that occurs with
free radical generation. Free radical damage to lipids results in
the production of MDA, which reacts with thiobarbituric acid
generating a chromogen that can be measured
spectrophotometrically. Rich lipid plasma was used to make
different samples [control sample: rich lipid
plasma + phosphate buffer saline (PBS); oxidation sample: rich
lipid plasma + CuSO4 (0.33 mg/mL); and plants extract sample:
rich lipid plasma + CuSO4 + plant extract (25, 50 or 100mg/mL)].
The absorbance of the red colored phase was measured in a
spectrophotometer at 532 nm. The quantity of TBARS was
calculated from a standard range of 1, 1, 3, 3,
tetramethoxypropane.
2.4.4. Hemolytic activity and protection against AAPH-
induced hemolysis
The hemolysis of erythrocytes were extensively used as an
ex vivo model for studying reactive oxygen species-induceddisruption of cell membranes and the protective effect of anti-
oxidants. One of the most frequently studied models is the
water-soluble azo compound (AAPH) that used for evaluation of
the antioxidant activity of the plant extract described by Prost
with modiﬁed [24]. The incubation of erythrocytes with AAPH
provoked the production of the peroxyl radical generated by
decomposition of AAPH in the presence of molecule oxygen
at 37 C. A rabbit erythrocyte suspension in PBS was used to
make different samples [control sample: erythrocyte
suspension in PBS; hemolysis sample: erythrocyte suspension
in PBS + AAPH; and plants extract sample: erythrocyte
suspensions in PBS + AAPH + plant extract (0.143 mg/mL)].
The erythrocyte suspension was mixed with 1 mL of thyme
extracts diluted with PBS. AAPH and PBS were then added to
the mixture. The reaction mixture was gently shaken during
incubation at 37 C and the absorbance was read at 540 nm
every 5 min. The protection of the erythrocytes of the extracts
was deduced from the time required for half-hemolysis (50%
reduction of A540 nm) compared to control values (PBS, pH
7.4).
2.5. Croton oil-induced ear edema in mice
The anti-inﬂammatory activity was measured as inhibition of
the croton oil-induced ear edema in mice according to the pro-
cedure established by Tubaro et al. with minor modiﬁcations
[16]. Skin inﬂammation was induced to the inner surface of the
right ear of mice (surface: about 1 cm2) by applying 240 mg
of croton oil dissolved in the same volume of 42% acetone/
ethanol (v/v) [aqueous extracts (900 mg/ear), and the relevant
controls]. The left ear remained untreated. The substances
under testing were applied together with the croton oil, except
for control animals which received only the irritant. The
evolution of right ear edema was determined at 2, 4 and 10 h.
As a reference, the non-steroidal anti-inﬂammatory drug indo-
methacin (500 mg/ear) was used. The anti-inﬂammatory activity
was expressed as ear edema rate and inhibition rate of edema in
treated mice with regard to control mice was calculated. The ear
edema rate and inhibition rate of each group were calculated as
follows:
Ear edema rate (%) = Vr − Vl/Vl
Inhibition rate (%) = Ec − Et/Ec
where Vr is the right ear volume (treated ear) and Vl is the
volume of the left ear (untreated ear); Ec is the ear edema rate of
the control group and Et is the ear edema rate of the treated
group.
2.6. Carrageenan-induced pleurisy in rats
According to the described method of Winter et al. [17], 30
rats equally were divided into ﬁve groups of six; they were
fasted for 16 h for experimentation. The initial volume (V0) of
the right hind paw was measured for each rat. The rats were
orally treated with indomethacin as standard anti-inﬂammatory
drug (10 mg/kg) (reference group) with PBS (control) or
aqueous thyme extracts (50 mg/kg). After 1 h of treatment, the
inﬂammation was inducted in rats by a subplantar injection of
0.1 mL of carrageenan suspension (100 mg/paw). The paw
volumes were determined hourly using a plethysmometer (Ugo
Figure 1. Comparison of the HPLC proﬁles from the tested Thymus ex-
tracts as detected at 280 nm.
A: Standards; B: T. zygis; C: T. atlanticus; D: T. satureioides; 1: Caffeic
acid; 2: Luteolin-7-glycoside; 3: Rosmarinic acid; 4: Daidzein; 5: Quer-
cetin; 6: Hesperetin; 7: Apigenin; 8: Thymol; 9: Carvacrol.
Table 1
Identiﬁed compounds and their retention times.
Plants Identiﬁed compound Retention time (min)
T. atlanticus Caffeic acid 11.60
Rosmarinic acid 17.00
Quercetin 21.20
T. zygis Caffeic acid 11.60
Rosmarinic acid 17.00
T. satureioides NI 13.70
Luteolin-7-glycoside 15.96
Rosmarinic acid 17.00
Hesperetin 22.00
NI: No identiﬁed compound.
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each group were calculated as follows:
Paw edema rate (%) = Vt − V0/V0
Inhibition rate (%) = Ec − Et/Ec
where Vt is the paw volume of the rat after carrageenan injection
and V0 is the paw volume of the rat before carrageenin injection;
Ec is the edema rate of the control group and Et is the edema rate
of the treated group.
2.7. Anticoagulant assays
All experiments were carried out six times, and were measured
automatically using coagulometer (Stago, STart 4). Two separate
assaysmeasuring APTT and PTwere carried out to investigate the
stage, at which extrinsic and intrinsic blood clotting pathways [25].
The anticoagulant activity of the series of the tested aqueous
thyme extracts at different concentrations was expressed in
seconds, as clotting time measured in APTT and PT tests. The
following concentrations of extracts were used in the clotting
mixtures: 11.43, 5.71, 2.86, 1.43, 0.71, 0.36 and 0.18 mg/mL.
Blood samples were collected by cardiac puncture with sy-
ringe from healthy rats in tubes containing 3.8% trisodium cit-
rate in a polypropylene container (9 parts of blood to 1 part of
trisodium citrate solution). It was immediately centrifuged at
25 000 r/min for 10 min, and plasma was separated and pooled.
The freshly prepared plasma was stored at 4 C until its use.
For APTT assay, normal citrated rat plasma (50 mL) was
mixed with a solution of a plant extracts (25 mL) and incubated
for 10 min at 37 C, then APTT reagent (C.K. Prest® provided
by Diagnostica Stago) (50 mL) was added to the mixture and
incubated for 5 min at 37 C. Thereafter clotting was induced by
adding 0.025 mol/L CaCl2 (50 mL) and clotting time was
recorded. In PT assay, normal citrated rat plasma (50 mL) was
mixed with a solution of plant extracts (25 mL) and incubated for
10 min. Then, PT reagent (Neoplastine® Cl provided by Diag-
nostica Stago) (100 mL), pre-incubated for 10 min at 37 C was
added and clotting time was recorded.
2.8. Statistical analysis
Statistical evaluation was carried out with StatView. Data
were expressed as mean ± SEM. Statistical differences were
evaluated by One-way ANOVA and the student's t-test. P values
<0.05 were considered statistically signiﬁcant.
3. Results
3.1. Biochemical analysis and antioxidant activities of
thyme extract
3.1.1. HPLC analysis of aqueous thyme extracts
The analysis of the typical HPLC chromatogram (Figure 1)
depicted that rosmarinic acid was present in all extracts at
relatively high levels and was the major phenolic acid. Quercetin
was the major ﬂavonoid especially in T. atlanticus. The extracts
of T. satureioides was particularly rich in luteolin-7-glycoside
and hesperetin was detected only in this plant. Rosmarinic
acid was expected to represent the single most antioxidative
constituent (Table 1).3.1.2. Determination of total phenols and ﬂavonoid
Thyme aqueous extracts were analysed for its phenolic
content by using Folin-Ciocalteu reagent. Folin-Ciocalteu re-
agent reacted nonspeciﬁcally with phenolic compounds; it also
reduced a number of non-phenolic compounds. From the results
summarized in Table 2, we can easily concluded that all three
varieties are rich in polyphenol and ﬂavonoid. The total poly-
phenol contents were between (475.00 ± 8.30) and
(495.47 ± 6.10) mg equivalent caffeic acid/g of extract. The
ﬂavonoid contents were between (155.11 ± 3.90) and
(208.13 ± 4.20) mg equivalent rutin/g of extract. Several
aqueous extracts displayed potent activity against both DPPH
and FRAP (Table 2). The IC50 values from three thyme varieties
were between (0.12 ± 0.02) and (0.44 ± 0.02) mg/mL of extract.
The FRAP assay showed that the antioxidant activity was be-
tween (40.02 ± 6.10) and (65.00 ± 9.40) mmol trolox/g of
extract.
3.2. Determination of MDA by TBARS
The MDA levels determined by TBARS method for three
concentrations of aqueous extracts (25, 50 and 100 mg/mL)
were given in Figure 2. The quantity of TBARS was calcu-
lated from a standard range of 1, 1, 3, 3, tetramethoxypropane.
The result of TBARS levels was expressed as MDA equiva-
lents (MDA nmol/L, mean ± SEM of three determinations).
The results showed that the aqueous extracts of thyme were
very signiﬁcantly inhibited the formation of MDA compared
to positive control. The amount of MDA observed in the
Table 2
Polyphenol content and antioxidant activity of thyme aqueous extracts from the three thyme varieties.
Extracts Polyphenols (mg equivalent
caffeic acid/g TAE)
Flavonoid (mg equivalent
rutin/g TAE)
Radical scavenging activity
[IC50 (mg/mL TAE)]
FRAP (mmol trolox/g
TAE)
T. zygis 482.92 ± 5.60 208.13 ± 4.20 0.44 ± 0.02* 65.00 ± 9.40
T. atlanticus 495.47 ± 6.10 155.11 ± 3.90 0.12 ± 0.02** 40.02 ± 6.10
T. satureioides 475.00 ± 8.30 182.79 ± 3.23 0.44 ± 0.01* 40.14 ± 4.55
Trolox – – 0.51 ± 0.01 44.33 ± 7.55
*: P < 0.01; **: P < 0.001; –: Absent; TAE: thyme aqueous extracts.
Figure 2. Effects of different concentrations of aqueous extracts of thyme
on lipid peroxidation product (MDA).
Results are expressed as mean ± SEM of three separate experiments; *:
P < 0.01; **: P < 0.001.
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observed in the negative control (P > 0.05). This indicated the
signiﬁcant lipid peroxidation inhibiting activity of thyme
varieties.
3.3. Hemolytic activity and protection against AAPH-
induced hemolysis
Table 3 shows the inhibition percentage of hemolysis, as a
result of protection against the oxidative damage of cell mem-
branes of erythrocytes from rat, induced by AAPH. Addition of
AAPH induced a signiﬁcant decrease in the half-time of he-
molysis from (73.33 ± 2.88) min to (40.00 ± 0.05) min (45%,
P < 0.001). Application of the aqueous extract from the three
varieties to the erythrocytes suspension with AAPH induced an
increase of half-time of hemolysis by 550% (P < 0.001), 470%
(P < 0.001), and 305% (P < 0.001) from T. satureioides,
T. atlanticus, and T. zygis, respectively. Trolox was used as
standard antioxidant that showed an increase of half-time of
hemolysis by 525% (P < 0.001). These results indicated that theTable 3
Antihemolytic activity of aqueous extracts of thyme.
Groups Hemolysis half-time (min) Deviation (%)
Control 73.33 ± 2.88
AAPH sample (%) 40.00 ± 0.05* −45
AAPH + T. atlanticus 228.33 ± 11.54* 470
AAPH + T. zygis 162.00 ± 35.38* 305
AAPH + T. satureioides 260.00 ± 17.32* 550
AAPH + trolox 250.00 ± 13.26* 525
* : P < 0.001; AAPH sample vs control; T. atlanticus, T. zygis,
T. satureioides and Trolox.aqueous thyme extracts had a greater protective effect against
hemolysis of erythrocytes.
3.4. Croton oil-induced mice ear edema
The anti-inﬂammatory activities of the all thyme aqueous
extracts were also tested using the croton oil-induced mice ear
edema model. Topical application of croton oil on the ears of
mice caused a signiﬁcant increase in the volume of the right ear
compared with the left ear (47.39% ± 0.50% at 8 h after the
treatment) (Table 4). In comparison with the non-steroidal anti-
inﬂammatory drug indomethacin, aqueous extracts of three
medicinal plants presented stronger and effective anti-
inﬂammatory activity in the experimental animal model used.
The ear edema was signiﬁcantly reduced after indomethacin
treatment (500 mg/ear) by 67.27%. Moreover, at 8 h after the
treatment, aqueous extract signiﬁcantly reduced the edema vol-
ume in comparison with control by 70.47%, 84.62% and 29.66%
at 900 mg/ear for T. zygis, T. atlanticus and T. satureioides
respectively.
3.5. Carrageenan-induced rat paw edema
The anti-inﬂammatory activities of aqueous extracts were
further evaluated by the inhibition of carrageenan-induced hind
paw edema in rats (Figure 3). After 5 h of treatment, compared
to the control (27.95% ± 0.06%), T. zygis and T. atlanticus
(50 mg/kg) signiﬁcantly reduced the carrageenan–induced paw
oedma volume (3.74% ± 0.01% and 9.52% ± 0.04% for T. zygis
and T. atlanticus, respectively) (P < 0.001) and their effect was
comparable to the reference drug indometacin (10 mg/kg)
(10.92% ± 0.06%) (P > 0.05) (Table 5). The aqueous extract of
T. zygis and T. atlanticus were found to possess potent anti-
inﬂammatory activity in the carrageenin-induced edema.
3.6. Anticoagulant activity
In our experiment, APTT and PT were used to evaluate the
anticoagulant effect of aqueous extract. Blood samples were
collected by cardiac puncture with syringe from healthy rats. In
APTT test, T. atlanticus and T. zygis extracts showed the
strongest anticoagulant activity (Table 6). They completely
inhibited the plasma clot formation in the concentrations of 2.86
and 5.72 mg/mL in the clotting mixtures, respectively, and both
strongly prolonged time of clotting still was the concentration of
0.18 mg/mL in the clotting mixtures (P < 0.01).
In PT test, T. atlanticus and T. zygis showed the strongest
anticoagulant activity (Table 7). These plants completely
inhibited clotting process at the concentrations of 5.72 and
11.43 mg/mL in clotting mixtures for T. atlanticus and T. zygis
Table 4
Anti-inﬂammatory activity of aqueous extracts of thyme in croton oil-induced mice ear edema.
Groups Ear edema rate (%)
2 h 4 h 6 h 8 h 10 h
Control 28.89 ± 0.75 41.31 ± 0.79 41.30 ± 0.60 47.39 ± 0.50 37.32 ± 0.67
T. zygis (900 mg/ear) 9.67 ± 0.55** 17.11 ± 0.54 24.85 ± 1.40*** 13.99 ± 0.54*** 9.67 ± 0.55***
T. atlanticus (900 mg/ear) 22.68 ± 1.68** 26.85 ± 0.98** 18.52 ± 0.71 7.29 ± 0.61*** 4.17 ± 0.65
T. satureioide (900 mg/ear) 11.04 ± 0.27 23.05 ± 0.48 40.13 ± 1.28 33.33 ± 1.36** 41.86 ± 0.22**
Indometacin (500 mg/ear) 34.02 ± 0.95 33.33 ± 1.36** 17.59 ± 0.72*** 15.51 ± 0.64*** 11.57 ± 0.07***
The animals were treated with aqueous extract of T. zygis, T. atlanticus or T. satureioides at 900 mg/ear. Indomethacin was used as a positive control
(500 mL/ear). The differences between treatment and control were tested using ANOVA. Values are expressed as mean ± SEM, (n = 6). **: P < 0.01
compared to control; ***: P < 0.001 compared to control.
Figure 3. Evolution of edema formation in rat paws (control).
The animals (n = 6) were treated with distillated water. Data obtained from
animal experiments were expressed as mean ± SEM.
Table 5
Anti-inﬂammatory activity of aqueous extracts of thyme in carrageenan-induced rats paw edema.
Groups Paw edema rate (%)
1 h 2 h 3 h 4 h 5 h 6 h 8 h 10 h 24 h
Control 5.35 ± 0.01 14.86 ± 0.03 23.53 ± 0.04 26.75 ± 0.06 27.95 ± 0.06 24.39 ± 0.07 21.93 ± 0.08 20.89 ± 0.07 10.55 ± 0.04
T. zygis
50 mg/kg
2.96 ± 0.01 4.14 ± 0.10** 5.10 ± 0.01** 4.68 ± 0.02** 3.74 ± 0.01** 3.12 ± 0.02** 2.56 ± 0.02* 2.20 ± 0.03** 1.97 ± 0.02*
T. atlanticus
50 mg/kg
8.06 ± 0.03 9.10 ± 0.03 10.40 ± 0.03** 9.52 ± 0.04** 9.52 ± 0.04** 9.23 ± 0.04* 6.98 ± 0.03* 6.52 ± 0.03* 5.62 ± 0.03
T. satureioides
50 mg/kg
5.13 ± 0.01 11.54 ± 0.03 13.69 ± 0.03** 17.28 ± 0.03 22.26 ± 0.03 22.21 ± 0.03 21.29 ± 0.03 20.58 ± 0.03 5.14 ± 0.01
Indometacin
50 mg/kg
6.23 ± 0.02 10.90 ± 0.02 11.50 ± 0.02** 11.61 ± 0.03** 10.92 ± 0.06** 10.52 ± 0.05* 8.70 ± 0.05 7.45 ± 0.04* 4.87 ± 0.04
The animals were treated with aqueous extract of T. zygis, T. atlanticus or T. satureioides at 50 mg/kg/ear. Indomethacin was used as a positive control
(10 mg/kg). The differences between treatment and control were tested using ANOVA. Values are expressed as mean ± SEM, (n = 6). *: P < 0.05
compared to control; **: P < 0.01 compared to control; ***: P < 0.001 compared to control.
Table 6
APTT measurements of aqueous extracts made in vitro experiments in rat
pooled plasma.
Concentrations
of a sample in
the clotting
mixture
(mg/mL)
In vitro APTT measurements (second)
T. zygis T. atlanticus T. satureioides
11.43 >900*** >900*** ND
5.71 >900*** >900*** ND
2.86 266.07 ± 7.98*** >900*** ND
1.43 47.87 ± 3.13** 68.97 ± 1.61*** ND
0.71 23.80 ± 0.56* 29.04 ± 0.60*** 13.23 ± 0.49*
0.36 19.97 ± 0.23** 19.64 ± 0.11*** 14.07 ± 0.19**
0.18 17.07 ± 0.36* 17.5 ± 0.26** 14.97 ± 0.05
Negative control 15.37 ± 0.14 15.37 ± 0.14 15.37 ± 0.14
Values are expressed as mean ± SEM of 6 measurements. ND: Not
determined; *: P < 0.05; **: P < 0.01; ***: P < 0.001. T. zygis,
T. atlanticus and T. satureioides vs negative control.
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Table 7
PT measurements of aqueous extracts made in vitro experiments in rat
pooled plasma.
Concentrations
of a sample in
the clotting
mixture (mg/mL)
In vitro PT measurements (second)
T. zygis T. atlanticus T. satureioides
11.43 >300*** >300*** ND
5.71 99.13 ± 1.47*** >300*** ND
2.86 27.27 ± 0.63*** 55.73 ± 1.98* ND
1.43 15.93 ± 0.55 20.40 ± 0.82** 13.27 ± 0.40
0.71 13.63 ± 0.37* 15.67 ± 0.31 13.87 ± 0.85
0.36 13.17 ± 0.14* 13.93 ± 0.14 14.57 ± 0.19
Negative control 14.67 ± 0.44 14.67 ± 0.44 14.67 ± 0.44
Values are expressed as mean ± SEM of 6 measurements. ND: Not
determined; *: P < 0.05; **: P < 0.01; ***: P < 0.001. T. zygis,
T. atlanticus and T. satureioides vs negative control.
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concentrations of 1.43 and 2.86 mg/mL in clotting mixtures for
T. atlanticus (P < 0.01) and T. zygis (P < 0.001) respectively.4. Discussion
The selection of the three species from the Thymus genus was
based on their traditional use for its anti-inﬂammatory properties
after topical or oral administration for the treatment of various
inﬂammatory diseases such as bronchitis and rheumatism. These
aromatic plants produce a large amount of secondary metabolites
(e.g. phenol compounds) that are able to exert beneﬁcial effects
for human well-being [26]. Considering the involvement of free
radicals in inﬂammation [27] and the relationship between
inﬂammation and the coagulation systems [28], the current
study aimed at analyzing the aqueous extracts of three
endemic medicinal plants (T. satureioides, T. zygis and
T. atlanticus) for their antioxidant, anti-inﬂammatory and anti-
coagulant activities. The results demonstrated that the three
varieties of thyme originating from the Errachidia area are rich in
total polyphenol and ﬂavonoid with rosmarinic acid which are
the major polyphenol compounds. Evaluation of antioxidant
activity for this extracts by different test shows that it possess a
high antioxidant. AAPH is a peroxy radical initiator that gen-
erates free radicals by its thermal decomposition and will protect
the erythrocytes to induce the chain oxidation of lipid and pro-
tein, disturb the membrane organization and eventually lead to
hemolysis. In this study, the protective effect of thyme extracts
on hemolysis by peroxyl radical scavenging activity was
investigated. The results indicated that the aqueous thyme ex-
tracts had a greater protective effect against hemolysis of
erythrocytes.
Croton oil induced ear edema is widely accepted as a useful
pharmacological model for the investigation of anti-
inﬂammatory effects. Its application of croton oil can induce
signiﬁcant inﬂammatory responses, as characterized by edema,
neutrophil inﬁltration, prostaglandins production and increases
in vascular permeability [29]. In summary, aqueous extracts of
these medicinal plants present a potent anti-inﬂammatory ac-
tivity. 12-O-tetradecanoylphorbol-13-acetate and other phorbol
esters are the primary irritants in croton oil. It has been reported
that cyclo-oxygenase inhibitors and 5-lipoxygenase inhibitors
are highly effective against inﬂammation caused by 12-O-tetradecanoylphorbol-13-acetate [30]. Also, polyphenol and
ﬂavonoid such as caffeic acid, quercetin, luteolin, have been
recognized as potent inhibitors of cyclo-oxygenase in different
studies [31–33]. These reports, together with our results, suggest a
possible relationship between the protective effects of aqueous
extracts in an acute inﬂammatory animal model and the rich
content of polyphenol in these extracts.
With the goal of proving the anti-inﬂammatory property of
three thymus, we evaluated the effects of aqueous extracts of
thyme on the carrageenan induced paw edema in rat. This
method was chosen for this study since it is the most prominent
experimental model in search for new anti-inﬂammatory drugs
and evaluation of anti-inﬂammatory effect of natural products
[34–36]. We found that the administration of aqueous extracts of
two Thymus (T. zygis and T. atlanticus) signiﬁcantly reduced the
carrageenan-induced paw edema. The evolution of paw edema
volume in control group is followed at 48 h; the maximum
volume of the edema is at 5 h after treatment. The injection of
carrageenan in rat produces a typical biphasic edema associated
with the production of several inﬂammatory mediators such as
histamine, serotonin, bradykinin, prostaglandins, nitric oxide
and cytokines [17,35]. It has been demonstrated that a different
proﬁle of inﬂammatory mediators involved with the ﬁrst and
second phases of the carrageenan induce paw edema in mice
[37] and demonstrated that treatment with the COX-1 inhibitor
reduce the early phase of paw edema. Moreover, COX-2 is up-
regulated only in the second phase [35]. According to the result
of our study, aqueous extract of T. zygis and T. atlanticus was
able to effectively inhibit the edema in both the earlier and in
the later phases, suggesting that extracts inhibit different
chemical mediators of inﬂammation.
The pre-clinical evaluation of the antithrombotic potential of
novel molecules requires the use of reliable and reproducible
experimental models. PT, APTT, ﬁbrin polymerization and
platelet aggregation are the most commonly used preparations to
determine the efﬁcacy of novel antithrombotic drugs [38]. In our
experiment, APTT and PT using rat plasma were used to
evaluate the anticoagulant effect of aqueous extract. The
APTT assay was used to determine the effects of aqueous
extract on intrinsic factors such as II, V, VIII, IX, XI and XII
and/or common pathways. The prolongation of the APTT was
indicative of the inhibition of the intrinsic factors and/or the
common pathways. PT evaluates the extrinsic and/or common
pathway of the coagulation cascade. The results of the APTT
and PT assay showed that aqueous extract of T. zygis and
T. atlanticus had prolonged coagulation times compared with
the control sample treated with PBS, suggesting that extracts
inhibited the common pathways. However, only
T. satureioides did not have signiﬁcant effect in these tests.
There is an evidence that inﬂammation and coagulation are
intricately related processes that may considerably affect each
other [28]. Systemic inﬂammation will invariably lead to activate
the coagulation system, but vice versa, components of the
coagulation system may markedly modulate the inﬂammatory
response [3]. On the basis of our current experimental studies,
it can be hypothesized that inhibitory modulation of
coagulation by extracts could give promising anti-
inﬂammatory mediators. Well-designed prospective studies are
needed to prove this hypothesis. These anti-inﬂammatory and
anticoagulant effects have been mostly attributed to the poly-
phenol and ﬂavonoid compounds found in large quantities in
these plants [29,34].
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species thymus. Recently, Rocha et al. showed that acid ros-
marinic possesses the high inﬂammatory effect evaluated by
different test in vitro and in vivo including carrageenan-induced
paw edema model [36]. All extracts possess the acid rosmarinic,
but not shows the similar anti-inﬂammatory effect in different
tests, suggesting the synergy between different compounds in
these inﬂammatory processes.
This study shows great variability of biological activities in
thyme varieties. All Thymus were found to possess considerable
antioxidant activities and are rich in total polyphenol and
ﬂavonoid compounds but the three extracts act differently on the
process of inﬂammatory and coagulation studied. The aqueous
extracts of T. atlanticus and T. zygis exhibited signiﬁcant anti-
inﬂammatory activity at both early and late phases in acute
and systemic inﬂammation. They act also on clotting and
oxidative stress in vitro studied. The activity may be doing a
cumulative of acid rosmarinic and other phytoconstituents.
Thus, the present study scientiﬁcally validated the traditional use
of aqueous extracts from some Thymus species in treatment of
inﬂammatory diseases.
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